$WOLV Cyber Crime ~ There's an App for That™ Ladies &

New Post Public Reply Private Reply Replies (0) Message Board
Lets Roll
$WOLV Cyber Crime ~ There's an App for That™
Ladies & Gentlemen
Cyber-crime is growing rapidly and is now crippling business and personal
identities on a daily basis. Today there are already in excess of 4 billion
mobile devices all running on Mobile Applications (software). Be they
from Apple, Google Android, BlackBerry or a host of others, they all have
an inherent flaw: none can protect or secure the device they run on from
hacking or intrusion with 100% certainty. (There are countless stories on the news web)

Security on computer equipment is now at a level of crisis; as was stated
by the US Government it is the single greatest threat to American
sovereignty - outweighing the War on Terrorism.

"How is this possible?"

The full answer is very complex as it is the same cause that has our
corporate and government computers the victims of billions of dollars in
losses from Cyber-crime and intrusion, fraud and intellectual property
theft. The short answer is that a software "App" must be watched at every
step as it internally processes data in order to keep it safe.

Thousands of companies have created technologies to watch data as it goes
"into" and "out of" the software, looking for anomalous or erroneous
activity that may have occurred. However none can watch the bit-by-bit
processing "inside" as the software is operating. No software can "watch
itself" to ensure the work it is doing is correct or authorized. There-in
lies the entire Cyber Security problem.

ENIGMAMobil™ has changed that paradigm and is creating ~ an app for that.

Within the first three pages of the easy read Investment document attached, you will
discover why the problem has never been solved before and what has now been
invented to solve this global crisis now.

What you are looking at here is a very rare world monopoly in one of the
largest revenue markets: Technology.

"Why doesn't someone else come up with the solution in the meantime?"

Quick Answer: The problem has been systemic for 45 years with no solution
and with the cyber crisis worsening every day, no one sees a short term
resolve. In fact, an $18 Billion contract was just pulled from one of the
largest security developers, CDC (for the Federal Government), by Congress
after 3 years into an attempt to solve the problem, citing the company had
made no acceptable progress toward a solution.

Even though the solution technology is fully patent protected (20yr), we do
not rest alone on that. ENIGMAMobil™ will be in the market 10 months
after this financing. Should another company attempt to create similar
software, they would not only be up against the patent, but the
game-changing language "Vulcan™( the patent name )", as discussed here-in, took a further 10
years of focused development to create. This "Vulcan™" language is
available exclusively to ENIGMAMobil™.

First to market solving a $2 Trillion dollar crisis has a clear "rite
of passage" for success. Patent aside again, the problem will have been
solved by ENIGMA, a new standard will have been set for security and the
spoils go to the victor.

To further enhance the investment the company has been structured with a
clear exit strategy in mind which is clearly defined inside the document.

This is a one-time opportunity for investment with no watering down to
follow. This is not so much about finding investors to risk - it is about
investors that are clear and informed on the problem and want to realize a
large gain for their knowledge of the magnitude of the problem.

I intend to have this financing closed in the short term. The market is
demanding a solution - the technology is ready.

Warm wishes,

David Chalk

(Dr.) David Chalk, d.Tech.
David Chalk Inc.
david@davidchalkinc.com

http://enigmamobile.com/

"You never change things by fighting the existing reality.
To change something, build a new model that makes the existing model
obsolete."
-- Richard Buckminster Fuller
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 1

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 0

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 2

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 0

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

UniFirst Corporation Increases Quarterly Cash Dividends

Updated Category News Views 140

UniFirst Corporation Announces Dividend Increase The Board of Directors of UniFirst Corporation (NYSE: UNF) has made a significant announcement regarding the company's shareholder dividends. Recently, they declared an increase in their quarterly cash dividends to $0.365 per share on the Company's Common Stock, and $0.292 per share on the Class B Common Stock. These...

Continue Reading
Arcutis Biotherapeutics Set to Join Health Conference

Updated Category News Views 64

Arcutis Biotherapeutics to Participate in Major Healthcare Conference Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a biopharmaceutical company in the commercial stage that specializes in innovative solutions for immuno-dermatology, is set to take part in an important healthcare conference. This event offers Arcutis a platform to showcase its advancements in dermatology...

Continue Reading
CTP Partners with Milšped for Major Logistics Expansion

Updated Category News Views 256

CTP Partners with Milšped for Major Logistics Expansion CTP, a leader in the development, ownership, and management of logistics and industrial properties in Europe, is proud to announce that it has signed significant new leases totaling 64,000 sqm with Milšped, a prominent logistics provider in Serbia and Southeast Europe. This expansion marks a tremendous step...

Continue Reading
Banc of California Stock Climbs to New Heights with Strong Growth

Updated Category News Views 38

Surge in Banc of California Stock Price Banc of California (NYSE: BANC) has achieved an impressive milestone, with its stock hitting a 52-week high of $15.55. This significant increase of 37.09% over the past year highlights the bank's strong performance in the competitive financial landscape. Investors are increasingly confident in the bank's growth prospects, as...

Continue Reading
What Lies Ahead for Qifu Technology's Earnings and Growth

Updated Category News Views 119

Understanding Qifu Technology's Upcoming Earnings Qifu Technology (NASDAQ: QFIN) is gearing up to release its quarterly earnings report soon. Investors have much to contemplate before the announcement. The anticipation surrounds whether the company will exceed earnings estimates, providing guidance that could sway future stock valuation. Analyst Expectations for Earnings...

Continue Reading